High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$16.4M
$16,377,649
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-02-13 | $204,180 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Howe Jolanda
• Officer • SVP, GLOBAL CONTROLLER
Sell to CoverΔOwn -17.7%
2026-02-02
$99,998
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Officer • SVP, GLOBAL CONTROLLER
Sell to CoverΔOwn -17.7%
|
2026-02-02 | $99,998 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $940,888 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Radovich Peter
• COO
Sell to CoverΔOwn -11.3%
2026-02-02
$271,792
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
COO
Sell to CoverΔOwn -11.3%
|
2026-02-02 | $271,792 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-01-26 | $101,290 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Howe Jolanda
• Officer • SVP, GLOBAL CONTROLLER
Sell to CoverΔOwn -18.5%
2026-01-26
$80,994
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Officer • SVP, GLOBAL CONTROLLER
Sell to CoverΔOwn -18.5%
|
2026-01-26 | $80,994 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-26 | $657,088 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Radovich Peter
• COO
Sell to CoverΔOwn -11.9%
2026-01-26
$302,331
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
COO
Sell to CoverΔOwn -11.9%
|
2026-01-26 | $302,331 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-01-22 | $132,615 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Howe Jolanda
• Officer • SVP, GLOBAL CONTROLLER
Sell to CoverΔOwn -23.3%
2026-01-22
$86,419
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Officer • SVP, GLOBAL CONTROLLER
Sell to CoverΔOwn -23.3%
|
2026-01-22 | $86,419 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-22 | $662,422 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Quan Joanne
• Officer • CHIEF MEDICAL OFFICER
Sell to CoverΔOwn -12.4%
2026-01-22
$170,039
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to CoverΔOwn -12.4%
|
2026-01-22 | $170,039 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Radovich Peter
• COO
Sell to CoverΔOwn -10.3%
2026-01-22
$222,301
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
COO
Sell to CoverΔOwn -10.3%
|
2026-01-22 | $222,301 | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Quan Joanne
• Officer • CHIEF MEDICAL OFFICER
Sell to CoverΔOwn -37.9%
2026-01-20
$623,853
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to CoverΔOwn -37.9%
|
2026-01-20 | $623,853 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-01-15 | $181,980 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-22 | $400,000 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-19 | $3,900,000Large | S | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Ramasastry Saira
• Director
10b5-1 SellΔOwn -50.0%
2025-12-18
$139,460x2
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -50.0%
|
2025-12-18 | $139,460x2 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $3,700,000Large | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-11-21 | $3,500,000Large | S | Form 4 |